Home/Dynocardia/Mark Kotfila, MSECE

MK

Mark Kotfila, MSECE

Lead, Strategic Partnerships

Therapeutic Areas

Dynocardia Pipeline

Drug	Indication	Phase
ViTrack Platform	Continuous Non-Invasive Blood Pressure (cNIBP) Monitoring	Clinical Trials

Leadership Team at Dynocardia

Mohan Thanikachalam, MD

Founder and CEO

Edward Adelson, PhD

Co-Founder & Core Technology Team Member

Abhijit Biswas, PhD

Co-Founder and CTO

Jose Wong, BS, MBA

Chief Product Officer

View full Dynocardia profile